Avantor (NYSE:AVTR) Given New $27.00 Price Target at Evercore ISI

Avantor (NYSE:AVTR) had its price target cut by Evercore ISI from $28.00 to $27.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have an outperform rating on the stock.

A number of other research analysts have also recently issued reports on AVTR. Robert W. Baird dropped their target price on shares of Avantor from $27.00 to $26.00 and set an outperform rating for the company in a report on Monday, April 29th. Barclays dropped their price objective on Avantor from $28.00 to $25.00 and set an overweight rating for the company in a research note on Friday, June 28th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Avantor from $23.00 to $25.00 and gave the stock a hold rating in a research report on Thursday, April 18th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, Avantor currently has an average rating of Moderate Buy and an average target price of $26.29.

Avantor Stock Down 0.9 %

Avantor stock opened at $20.58 on Tuesday. The stock’s 50 day moving average price is $23.66 and its 200 day moving average price is $23.81. Avantor has a 1-year low of $16.63 and a 1-year high of $26.16. The company has a market cap of $13.98 billion, a PE ratio of 52.77, a price-to-earnings-growth ratio of 2.15 and a beta of 1.32. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.61 and a quick ratio of 1.05.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business’s revenue was down 5.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.29 EPS. On average, sell-side analysts predict that Avantor will post 1.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Avantor

Several institutional investors and hedge funds have recently modified their holdings of AVTR. Fifth Third Bancorp grew its holdings in Avantor by 125.3% in the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after buying an additional 694 shares during the period. Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after acquiring an additional 1,131 shares during the last quarter. Gladius Capital Management LP purchased a new stake in Avantor in the fourth quarter valued at approximately $42,000. Montag A & Associates Inc. acquired a new position in Avantor during the fourth quarter worth approximately $43,000. Finally, TFO Wealth Partners LLC raised its stake in Avantor by 203,100.0% during the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock worth $46,000 after purchasing an additional 2,031 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.